Physician profile
Keith R Eppich
NPI 1619985629
$6,200.05
in general payments reported to CMS, 2019-2025
55 companies · $821 in 2025
The $821 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $993 · 2020: $245 · 2021: $484 · 2022: $1,201 · 2023: $1,207 · 2024: $1,249 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,276.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $919.28 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $848.42 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $749.02 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $608.07 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $421.73 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $271.48 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $198.37 | 2019-2023 | Steglatro, Belsomra |
| Pfizer INC. | $190.92 | 2019-2025 | |
| Corium, LLC | $161.99 | 2022-2023 | Azstarys |
| Bayer Healthcare Pharmaceuticals INC. | $113.10 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $107.18 | 2019-2024 | Spravato |
| Inari Medical, INC. | $89.12 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astellas Pharma US INC | $88.91 | 2025 | Veozah |
| Abbott Laboratories | $80.54 | 2019-2025 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $77.27 | 2019 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Eppich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.